Lung Diseases Cochrane Pediatric Emergency Medicine Reviews
Browse Cochrane Pediatric Emergency Medicine Reviews
Browse Cochrane Pediatric Emergency Medicine Reviews
Cochrane Systematic Review: Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
Cochrane Systematic Review: Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
- Visit
Lands LC, Stanojevic S
Lands LC, Stanojevic S
OBJECTIVES: To assess the effectiveness of treatment with NSAIDs in CF.
OBJECTIVES: To assess the effectiveness of treatment with NSAIDs in CF.
Cochrane Systematic Review: Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
Cochrane Systematic Review: Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
- Visit
Hurley MN, Forrester DL, Smyth AR
Hurley MN, Forrester DL, Smyth AR
OBJECTIVES: To determine if antibiotic adjuvants improve clinical and microbiological outcome of pulmonary infection in people with cystic fibrosis.
OBJECTIVES: To determine if antibiotic adjuvants improve clinical and microbiological outcome of pulmonary infection in people with cystic fibrosis.
Cochrane Systematic Review: Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
Cochrane Systematic Review: Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
- Visit
Lands LC, Stanojevic S
Lands LC, Stanojevic S
OBJECTIVES: To assess the effectiveness of treatment with NSAIDs in CF.
OBJECTIVES: To assess the effectiveness of treatment with NSAIDs in CF.
Cochrane Systematic Review: Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
Cochrane Systematic Review: Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
- Visit
Hurley MN, Forrester DL, Smyth AR
Hurley MN, Forrester DL, Smyth AR
OBJECTIVES: To determine if antibiotic adjuvants improve clinical and microbiological outcome of pulmonary infection in people with cystic fibrosis.
OBJECTIVES: To determine if antibiotic adjuvants improve clinical and microbiological outcome of pulmonary infection in people with cystic fibrosis.
